PMID: 40486Jan 1, 1979

Comparative study of the neuromuscular effects of 3 curare-like agents in children

Annales de l'anesthésiologie française
G NishanA Mathieu


The authors studied the effect of three curare-like agents in 92 children anesthetised with halothane (1 to 2 p. 100). The method used was to give increasing doses of d-tubocurarine, metocurine and pancuronium bromide by injection until a block of approximately 95 p. 100 of the contraction of the thumb was obtained. This was checked by electrostimulation. Each of the three groups of children who were treated with one of the three curare-like agents were subdivided according to age and dose-response curves were obtained. The time required to recover 10 and 25 p. 100 of a control contraction was also studied. The authors conclude that from the point-of-view of activity, metocurine and pancuronium are respectively twice and five times more powerful than d-tubocurarine. The recovery time for pancuronium is twice as short as that for metocurine and d-tubocurarine. Furthermore, even though they are more resistant than adults, children recover more quickly than them. There is no difference in sensitivity in children that could be related to age, and this was so in the three curare-like agents studied. However, individual differences were more marked in neo-natal infants of less than 10 days than in other groups.

Related Concepts

Contraction (Finding)
Neuromuscular Nondepolarizing Agents
Neuromuscular Effect
Pancuronium Curamed
Tubocurarine Chloride
Dose-Response Relationship, Drug

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.